Rhonda Patrick· PhD
in a study involving 66 thousand nine hundred and forty women those women with the high luteolin intake had a 34% decrease in cancer incidence compared to those women with the lowest luteolin intake.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in a study involving 66 thousand nine hundred and forty women those women with the high luteolin intake had a 34% decrease in cancer incidence compared to those women with the lowest luteolin intake.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.